Skip to main content
Top
Published in: BMC Public Health 1/2011

Open Access 01-12-2011 | Research article

The potential impact of immunization campaign budget re-allocation on global eradication of paediatric infectious diseases

Authors: Tiffany Fitzpatrick, Chris T Bauch

Published in: BMC Public Health | Issue 1/2011

Login to get access

Abstract

Background

The potential benefits of coordinating infectious disease eradication programs that use campaigns such as supplementary immunization activities (SIAs) should not be over-looked. One example of a coordinated approach is an adaptive "sequential strategy": first, all annual SIA budget is dedicated to the eradication of a single infectious disease; once that disease is eradicated, the annual SIA budget is re-focussed on eradicating a second disease, etc. Herd immunity suggests that a sequential strategy may eradicate several infectious diseases faster than a non-adaptive "simultaneous strategy" of dividing annual budget equally among eradication programs for those diseases. However, mathematical modeling is required to understand the potential extent of this effect.

Methods

Our objective was to illustrate how budget allocation strategies can interact with the nonlinear nature of disease transmission to determine time to eradication of several infectious diseases under different budget allocation strategies. Using a mathematical transmission model, we analyzed three hypothetical vaccine-preventable infectious diseases in three different countries. A central decision-maker can distribute funding among SIA programs for these three diseases according to either a sequential strategy or a simultaneous strategy. We explored the time to eradication under these two strategies under a range of scenarios.

Results

For a certain range of annual budgets, all three diseases can be eradicated relatively quickly under the sequential strategy, whereas eradication never occurs under the simultaneous strategy. However, moderate changes to total SIA budget, SIA frequency, order of eradication, or funding disruptions can create disproportionately large differences in the time and budget required for eradication under the sequential strategy. We find that the predicted time to eradication can be very sensitive to small differences in the rate of case importation between the countries. We also find that the time to eradication of all three diseases is not necessarily lowest when the least transmissible disease is targeted first.

Conclusions

Relatively modest differences in budget allocation strategies in the near-term can result in surprisingly large long-term differences in time required to eradicate, as a result of the amplifying effects of herd immunity and the nonlinearities of disease transmission. More sophisticated versions of such models may be useful to large international donors or other organizations as a planning or portfolio optimization tool, where choices must be made regarding how much funding to dedicate to different infectious disease eradication efforts.
Appendix
Available only for authorised users
Literature
1.
go back to reference McNeill WH: Plagues and Peoples. 1998, New York: Anchor Books McNeill WH: Plagues and Peoples. 1998, New York: Anchor Books
2.
go back to reference Oldstone MBA: Viruses, Plagues, & History. 2010, New York: Oxford University Press Oldstone MBA: Viruses, Plagues, & History. 2010, New York: Oxford University Press
3.
go back to reference Harrison M: Disease and the Modern World: 1500 to the Present Day. 2007, Malden, MA: Polity Press Harrison M: Disease and the Modern World: 1500 to the Present Day. 2007, Malden, MA: Polity Press
4.
go back to reference Renne E: Perspectives on polio and immunization in Northern Nigeria. Social Science & Medicine. 2006, 63: 1857-1869. 10.1016/j.socscimed.2006.04.025.CrossRef Renne E: Perspectives on polio and immunization in Northern Nigeria. Social Science & Medicine. 2006, 63: 1857-1869. 10.1016/j.socscimed.2006.04.025.CrossRef
7.
go back to reference Centers for Disease Control and Prevention (CDC), Hamborsky J, et al: Epidemiology and Prevention of Vaccine Preventable Diseases. 2009, Washington DC: Public Health Foundation, 11 Centers for Disease Control and Prevention (CDC), Hamborsky J, et al: Epidemiology and Prevention of Vaccine Preventable Diseases. 2009, Washington DC: Public Health Foundation, 11
10.
go back to reference Feroz F, et al: Nationwide Measles Vacciantion Campaign for Children Aged 6 Months -- 12 Years -- Afghanistan. Morbidity and mortality Weekly Report (MMWR). 2003, 363-366. Feroz F, et al: Nationwide Measles Vacciantion Campaign for Children Aged 6 Months -- 12 Years -- Afghanistan. Morbidity and mortality Weekly Report (MMWR). 2003, 363-366.
12.
go back to reference Anderson RM, May R: Infectious Disease of Humans- Dynamics and Control. 1991, New York: Oxford University Press Anderson RM, May R: Infectious Disease of Humans- Dynamics and Control. 1991, New York: Oxford University Press
14.
go back to reference Grabowsky M, et al: Distributing insecticide-treated bednets during measles vaccination: a low-cost means of achieving high and equitable coverage. Bulletin of the World Health Organization. 2005, 83: 195-201.PubMedPubMedCentral Grabowsky M, et al: Distributing insecticide-treated bednets during measles vaccination: a low-cost means of achieving high and equitable coverage. Bulletin of the World Health Organization. 2005, 83: 195-201.PubMedPubMedCentral
15.
go back to reference Carabin H, et al: The average cost of measles cases and adverse events following vaccination in industrialised countries. BMC Public Health. 2002, 2: 22-35. 10.1186/1471-2458-2-22.CrossRefPubMedPubMedCentral Carabin H, et al: The average cost of measles cases and adverse events following vaccination in industrialised countries. BMC Public Health. 2002, 2: 22-35. 10.1186/1471-2458-2-22.CrossRefPubMedPubMedCentral
17.
go back to reference Tebbens RJD, Thompson KM: Priority Shifting and the Dynamics of Managing Eradicable Infectious Diseases. Management Science. 2009, 55: 650-663. 10.1287/mnsc.1080.0965.CrossRef Tebbens RJD, Thompson KM: Priority Shifting and the Dynamics of Managing Eradicable Infectious Diseases. Management Science. 2009, 55: 650-663. 10.1287/mnsc.1080.0965.CrossRef
18.
go back to reference Mossong J, Muller CP: Modelling measles re-emergence as a result of waning of immunity in vaccinated populations. Vaccine. 2003, 21: 4597-4603. 10.1016/S0264-410X(03)00449-3.CrossRefPubMed Mossong J, Muller CP: Modelling measles re-emergence as a result of waning of immunity in vaccinated populations. Vaccine. 2003, 21: 4597-4603. 10.1016/S0264-410X(03)00449-3.CrossRefPubMed
19.
go back to reference Wolfson LJ, et al: Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study. The Lancet. 2007, 369: 191-200. 10.1016/S0140-6736(07)60107-X.CrossRef Wolfson LJ, et al: Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study. The Lancet. 2007, 369: 191-200. 10.1016/S0140-6736(07)60107-X.CrossRef
20.
go back to reference Bauch CT, Szusz E, Garrison LP: Scheduling of measles vaccination in low-income countries: Projections of a dynamic model. Vaccine. 2009, 27: 4090-4098. 10.1016/j.vaccine.2009.04.079.CrossRefPubMed Bauch CT, Szusz E, Garrison LP: Scheduling of measles vaccination in low-income countries: Projections of a dynamic model. Vaccine. 2009, 27: 4090-4098. 10.1016/j.vaccine.2009.04.079.CrossRefPubMed
21.
go back to reference Clemens J, Jodar L: Introducing new vaccines into developing countries: obstacles, opportunities, and complexities. Nature Medicine Supplement. 2005, 11: S12-S15. 10.1038/nm1225.CrossRef Clemens J, Jodar L: Introducing new vaccines into developing countries: obstacles, opportunities, and complexities. Nature Medicine Supplement. 2005, 11: S12-S15. 10.1038/nm1225.CrossRef
22.
go back to reference Ferrari MJ, Grais RF, Bharti N, Conlan AKJ, Bjornstad ON, et al: The dynamics of measles in sub-Saharan Africa. Nature. 2008, 451: 679-684. 10.1038/nature06509.CrossRefPubMed Ferrari MJ, Grais RF, Bharti N, Conlan AKJ, Bjornstad ON, et al: The dynamics of measles in sub-Saharan Africa. Nature. 2008, 451: 679-684. 10.1038/nature06509.CrossRefPubMed
24.
go back to reference Bauch CT, Earn DJD: Transients and Attractors in Epidemics. Proceedings of the Royal Society of London B. 2003, 270: 1573-1578. 10.1098/rspb.2003.2410.CrossRef Bauch CT, Earn DJD: Transients and Attractors in Epidemics. Proceedings of the Royal Society of London B. 2003, 270: 1573-1578. 10.1098/rspb.2003.2410.CrossRef
29.
go back to reference Rainey JJ, et al: Providing monovalent oral polio vaccine type 1 to newborns: findings from a pilot birth-dose project in Moradabad district, India. Bulletin of the World Health Organization (BLT). 2009, 87: 955-959. 10.2471/BLT.08.061556.CrossRef Rainey JJ, et al: Providing monovalent oral polio vaccine type 1 to newborns: findings from a pilot birth-dose project in Moradabad district, India. Bulletin of the World Health Organization (BLT). 2009, 87: 955-959. 10.2471/BLT.08.061556.CrossRef
30.
go back to reference Khan MM, Ehreth J: Costs and benefits of polio eradication: a long-run global perspective. Vaccine. 2003, 21: 702-705. 10.1016/S0264-410X(02)00584-4.CrossRefPubMed Khan MM, Ehreth J: Costs and benefits of polio eradication: a long-run global perspective. Vaccine. 2003, 21: 702-705. 10.1016/S0264-410X(02)00584-4.CrossRefPubMed
31.
go back to reference Dabral M: Cost-effectiveness of Supplementary Immunization for Measles in India. Indian Pediatrics. 2009, 46: 957-962.PubMed Dabral M: Cost-effectiveness of Supplementary Immunization for Measles in India. Indian Pediatrics. 2009, 46: 957-962.PubMed
32.
go back to reference Madhavi Y: New combination vaccines: backdoor entry into India's universal immunization programme?. Current Science. 2006, 90: 1465-1469. Madhavi Y: New combination vaccines: backdoor entry into India's universal immunization programme?. Current Science. 2006, 90: 1465-1469.
33.
go back to reference Thompson KM, Tebbens RJD: Eradication versus control for poliomyelitis: an economic analysis. Lancet. 2007, 369: 1363-1371. 10.1016/S0140-6736(07)60532-7.CrossRefPubMed Thompson KM, Tebbens RJD: Eradication versus control for poliomyelitis: an economic analysis. Lancet. 2007, 369: 1363-1371. 10.1016/S0140-6736(07)60532-7.CrossRefPubMed
34.
go back to reference Earn DJD, Rohani P, Grenfell BT: Persistence, chaos, and synchrony in ecology and epidemiology. Proceedings: Biological Sciences. 1998, 265: 7-10. 10.1098/rspb.1998.0256.PubMedCentral Earn DJD, Rohani P, Grenfell BT: Persistence, chaos, and synchrony in ecology and epidemiology. Proceedings: Biological Sciences. 1998, 265: 7-10. 10.1098/rspb.1998.0256.PubMedCentral
35.
go back to reference Szusz EK, Garrison LP, Bauch CT: A review of data needed to parameterize a dynamic model of measles in developing countries. BMC Research Notes. 3: 75- Szusz EK, Garrison LP, Bauch CT: A review of data needed to parameterize a dynamic model of measles in developing countries. BMC Research Notes. 3: 75-
Metadata
Title
The potential impact of immunization campaign budget re-allocation on global eradication of paediatric infectious diseases
Authors
Tiffany Fitzpatrick
Chris T Bauch
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2011
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-11-739

Other articles of this Issue 1/2011

BMC Public Health 1/2011 Go to the issue